Search

Juan Carlos Turriate Gastulo

Examiner (ID: 2742)

Most Active Art Unit
2446
Art Unit(s)
2446
Total Applications
424
Issued Applications
288
Pending Applications
50
Abandoned Applications
105

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5638039 [patent_doc_number] => 20060069013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Pharmaceutical preparations comprising acid-stabilised insulin' [patent_app_type] => utility [patent_app_number] => 11/227760 [patent_app_country] => US [patent_app_date] => 2005-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 88262 [patent_no_of_claims] => 129 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20060069013.pdf [firstpage_image] =>[orig_patent_app_number] => 11227760 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/227760
Pharmaceutical preparations comprising acid-stabilised insulin Sep 11, 2005 Abandoned
Array ( [id] => 5028451 [patent_doc_number] => 20070269898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'Amino Acid Sequences Essential to Neuron Specific Gene Expression' [patent_app_type] => utility [patent_app_number] => 11/662982 [patent_app_country] => US [patent_app_date] => 2005-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7640 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20070269898.pdf [firstpage_image] =>[orig_patent_app_number] => 11662982 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/662982
Amino Acid Sequences Essential to Neuron Specific Gene Expression Sep 11, 2005 Abandoned
Array ( [id] => 348956 [patent_doc_number] => 07495072 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-24 [patent_title] => 'Process for preparation of mixtures of polypeptides using purified hydrobromic acid' [patent_app_type] => utility [patent_app_number] => 11/223072 [patent_app_country] => US [patent_app_date] => 2005-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6490 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/495/07495072.pdf [firstpage_image] =>[orig_patent_app_number] => 11223072 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/223072
Process for preparation of mixtures of polypeptides using purified hydrobromic acid Sep 8, 2005 Issued
Array ( [id] => 5895404 [patent_doc_number] => 20060003943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Protease enzyme inhibitors' [patent_app_type] => utility [patent_app_number] => 11/221445 [patent_app_country] => US [patent_app_date] => 2005-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6548 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20060003943.pdf [firstpage_image] =>[orig_patent_app_number] => 11221445 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/221445
Protease enzyme inhibitors Sep 7, 2005 Abandoned
Array ( [id] => 5794020 [patent_doc_number] => 20060014701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Novel amide derivatives as growth hormone secretagogues' [patent_app_type] => utility [patent_app_number] => 11/218562 [patent_app_country] => US [patent_app_date] => 2005-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30932 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014701.pdf [firstpage_image] =>[orig_patent_app_number] => 11218562 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/218562
Novel amide derivatives as growth hormone secretagogues Sep 5, 2005 Abandoned
Array ( [id] => 369884 [patent_doc_number] => 07476657 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-13 [patent_title] => 'Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments' [patent_app_type] => utility [patent_app_number] => 11/221348 [patent_app_country] => US [patent_app_date] => 2005-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 25411 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/476/07476657.pdf [firstpage_image] =>[orig_patent_app_number] => 11221348 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/221348
Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments Sep 5, 2005 Issued
Array ( [id] => 5710967 [patent_doc_number] => 20060052312 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Paclitaxel hybrid derivatives' [patent_app_type] => utility [patent_app_number] => 11/221391 [patent_app_country] => US [patent_app_date] => 2005-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4581 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20060052312.pdf [firstpage_image] =>[orig_patent_app_number] => 11221391 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/221391
Paclitaxel hybrid derivatives Sep 5, 2005 Abandoned
Array ( [id] => 5710054 [patent_doc_number] => 20060051399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Remedies for liver diseases, hyperlipemia and diabetes' [patent_app_type] => utility [patent_app_number] => 11/211688 [patent_app_country] => US [patent_app_date] => 2005-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7185 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20060051399.pdf [firstpage_image] =>[orig_patent_app_number] => 11211688 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/211688
Remedies for liver diseases, hyperlipemia and diabetes Aug 25, 2005 Abandoned
Array ( [id] => 4759918 [patent_doc_number] => 20080312144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Peptides for the Treatment of Herpes Virus Infections' [patent_app_type] => utility [patent_app_number] => 11/658269 [patent_app_country] => US [patent_app_date] => 2005-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2247 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20080312144.pdf [firstpage_image] =>[orig_patent_app_number] => 11658269 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/658269
Peptides for the treatment of herpes virus infections Aug 15, 2005 Issued
Array ( [id] => 475310 [patent_doc_number] => 07226906 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-05 [patent_title] => 'Cyclosporin analogs for the treatment of immunoregulatory disorders and respiratory diseases' [patent_app_type] => utility [patent_app_number] => 11/201478 [patent_app_country] => US [patent_app_date] => 2005-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14972 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/226/07226906.pdf [firstpage_image] =>[orig_patent_app_number] => 11201478 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/201478
Cyclosporin analogs for the treatment of immunoregulatory disorders and respiratory diseases Aug 10, 2005 Issued
Array ( [id] => 5241820 [patent_doc_number] => 20070020312 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Method of fabricating a bioactive agent-releasing implantable medical device' [patent_app_type] => utility [patent_app_number] => 11/186030 [patent_app_country] => US [patent_app_date] => 2005-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7853 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20070020312.pdf [firstpage_image] =>[orig_patent_app_number] => 11186030 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/186030
Method of fabricating a bioactive agent-releasing implantable medical device Jul 19, 2005 Abandoned
Array ( [id] => 5771590 [patent_doc_number] => 20050267041 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Tetrapeptide derivative crystals' [patent_app_type] => utility [patent_app_number] => 11/180582 [patent_app_country] => US [patent_app_date] => 2005-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3236 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20050267041.pdf [firstpage_image] =>[orig_patent_app_number] => 11180582 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/180582
Method of making tetrapeptide derivative TZT-1027 crystal Jul 13, 2005 Issued
Array ( [id] => 5793996 [patent_doc_number] => 20060014677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Method for maximizing efficacy and predicting and minimizing toxicity of calcineurin inhibitor compounds' [patent_app_type] => utility [patent_app_number] => 11/181580 [patent_app_country] => US [patent_app_date] => 2005-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9473 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014677.pdf [firstpage_image] =>[orig_patent_app_number] => 11181580 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/181580
Method for maximizing efficacy and predicting and minimizing toxicity of calcineurin inhibitor compounds Jul 12, 2005 Abandoned
Array ( [id] => 228989 [patent_doc_number] => 07601802 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-13 [patent_title] => 'Cysteine-containing peptides having antioxidant properties' [patent_app_type] => utility [patent_app_number] => 11/177225 [patent_app_country] => US [patent_app_date] => 2005-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14450 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/601/07601802.pdf [firstpage_image] =>[orig_patent_app_number] => 11177225 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/177225
Cysteine-containing peptides having antioxidant properties Jul 6, 2005 Issued
Array ( [id] => 5625343 [patent_doc_number] => 20060263848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Cysteine-containing peptides having antioxidant properties' [patent_app_type] => utility [patent_app_number] => 11/177237 [patent_app_country] => US [patent_app_date] => 2005-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14375 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20060263848.pdf [firstpage_image] =>[orig_patent_app_number] => 11177237 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/177237
Cysteine-containing peptides having antioxidant properties Jul 6, 2005 Issued
Array ( [id] => 5688927 [patent_doc_number] => 20060287242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Human glucagon-like-peptide-1 modulators and their use in treatment of diabetes and related conditions' [patent_app_type] => utility [patent_app_number] => 11/170968 [patent_app_country] => US [patent_app_date] => 2005-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 38964 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20060287242.pdf [firstpage_image] =>[orig_patent_app_number] => 11170968 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/170968
Human glucagon-like-peptide-1 modulators and their use in treatment of diabetes and related conditions Jun 29, 2005 Issued
Array ( [id] => 159760 [patent_doc_number] => 07674915 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-09 [patent_title] => 'Process for manufacturing a glutamic acid derivative and a pyroglutamic acid derivative and a novel intermediate in the manufacture thereof' [patent_app_type] => utility [patent_app_number] => 11/169677 [patent_app_country] => US [patent_app_date] => 2005-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10341 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/674/07674915.pdf [firstpage_image] =>[orig_patent_app_number] => 11169677 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/169677
Process for manufacturing a glutamic acid derivative and a pyroglutamic acid derivative and a novel intermediate in the manufacture thereof Jun 29, 2005 Issued
Array ( [id] => 210551 [patent_doc_number] => 07625869 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-01 [patent_title] => 'Metastin derivatives and use thereof' [patent_app_type] => utility [patent_app_number] => 11/630698 [patent_app_country] => US [patent_app_date] => 2005-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 98846 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/625/07625869.pdf [firstpage_image] =>[orig_patent_app_number] => 11630698 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/630698
Metastin derivatives and use thereof Jun 22, 2005 Issued
Array ( [id] => 369880 [patent_doc_number] => 07476653 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-13 [patent_title] => 'Macrocyclic modulators of the ghrelin receptor' [patent_app_type] => utility [patent_app_number] => 11/149731 [patent_app_country] => US [patent_app_date] => 2005-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 34 [patent_no_of_words] => 63748 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/476/07476653.pdf [firstpage_image] =>[orig_patent_app_number] => 11149731 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/149731
Macrocyclic modulators of the ghrelin receptor Jun 9, 2005 Issued
Array ( [id] => 352673 [patent_doc_number] => 07491695 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-17 [patent_title] => 'Methods of using macrocyclic modulators of the ghrelin receptor' [patent_app_type] => utility [patent_app_number] => 11/149512 [patent_app_country] => US [patent_app_date] => 2005-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 34 [patent_no_of_words] => 63772 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/491/07491695.pdf [firstpage_image] =>[orig_patent_app_number] => 11149512 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/149512
Methods of using macrocyclic modulators of the ghrelin receptor Jun 9, 2005 Issued
Menu